Alli Marketing: While Vitamins Are Friendly, Some Supplements Are Foes
This article was originally published in The Pink Sheet Daily
Executive Summary
GlaxoSmithKline eyes $1 billion market for supplement weight-loss therapy alli, a first-in-class switch of orlistat, with initial promotions highlighting unapproved nature of dietary supplements.